Expect Equity LLC Has $2.84 Million Position in The Cooper Companies, Inc. $COO

Expect Equity LLC lifted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 29.0% in the 4th quarter, Holdings Channel reports. The institutional investor owned 34,620 shares of the medical device company’s stock after purchasing an additional 7,790 shares during the quarter. Cooper Companies accounts for about 2.7% of Expect Equity LLC’s investment portfolio, making the stock its 12th biggest holding. Expect Equity LLC’s holdings in Cooper Companies were worth $2,837,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently modified their holdings of the company. Root Financial Partners LLC boosted its position in shares of Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after buying an additional 162 shares during the period. Bell Investment Advisors Inc boosted its position in shares of Cooper Companies by 106.3% during the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after buying an additional 219 shares during the period. CYBER HORNET ETFs LLC acquired a new position in Cooper Companies during the second quarter valued at approximately $36,000. True Wealth Design LLC boosted its position in Cooper Companies by 484.8% during the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock valued at $38,000 after purchasing an additional 383 shares during the last quarter. Finally, Cromwell Holdings LLC boosted its position in Cooper Companies by 128.8% during the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after purchasing an additional 273 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. BNP Paribas Exane reduced their price target on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a research report on Monday, June 8th. JPMorgan Chase & Co. reduced their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research report on Friday, June 5th. The Goldman Sachs Group set a $61.00 price target on Cooper Companies in a research report on Wednesday, May 27th. Citigroup reissued a “neutral” rating and set a $69.00 price target (down from $80.00) on shares of Cooper Companies in a research report on Thursday, May 28th. Finally, KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies has a consensus rating of “Hold” and a consensus target price of $81.31.

Cooper Companies Stock Performance

COO opened at $65.05 on Thursday. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The stock has a market cap of $12.69 billion, a price-to-earnings ratio of 55.13, a PEG ratio of 1.76 and a beta of 0.87. The business has a 50 day moving average of $64.58 and a 200-day moving average of $74.10. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business’s revenue was up 7.9% on a year-over-year basis. During the same period last year, the firm posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities research analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.